Zyrorab L 75mg/20mg Capsule SR
Images are for reference. Actual packaging may vary.
1 units • OtherPrescription requiredSchedule H
Zyrorab L 75mg/20mg Capsule SR
Levosulpiride (75mg) + Rabeprazole (20mg)
₹160.00
1 units • Other
A valid prescription is required for this medicine.
1
Delivery
Safe & Secure
Easy Returns
24/7 Support
SMARTER CARE
A little guidance.
A better choice.
Haven’t found an alternative? A health advisor can help you understand what to do next.
No matching alternative found
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Rabeprazole 20 mg
+1 more active ingredient
How It Works
Rabeprazole irreversibly inhibits the H+/K+ ATPase enzyme in gastric parietal cells, reducing gastric acid secretion.
Medicine Strength
20 mg
All Active Ingredients
Rabeprazole20 mg
Levosulpiride75 mg
Uses & Benefits
Medical applications
HeadacheFluUlcerNausea
Zyrorab L 75mg/20mg Capsule SR is a combination medication containing Levosulpiride 75mg and Rabeprazole 20mg, formulated for sustained release to provide prolonged therapeutic effects. Levosulpiride is a selective dopamine D2 receptor antagonist with prokinetic and antiemetic properties, commonly used to treat gastrointestinal motility disorders such as functional dyspepsia, gastroparesis, and irritable bowel syndrome.
Read full descriptionShow less
It enhances gastric emptying and improves esophageal motility, thereby alleviating symptoms like nausea, vomiting, bloating, and abdominal discomfort. Rabeprazole, a proton pump inhibitor, suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system in gastric parietal cells, making it effective in managing acid-related disorders including gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome.
The combination of Levosulpiride and Rabeprazole in Zyrorab L provides a dual mechanism targeting both motility and acid secretion abnormalities, offering symptomatic relief and promoting mucosal healing. This formulation is indicated for patients with concomitant acid peptic disease and motility disturbances. Zyrorab L should be used under medical supervision, with caution in patients with renal or hepatic impairment, and is contraindicated in individuals with hypersensitivity to its components.
Common adverse effects may include headache, dizziness, and mild gastrointestinal disturbances.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Safety information not available for this product. Please consult your doctor or pharmacist.
Customer Reviews
0 reviews for Zyrorab L 75mg/20mg Capsule SR
